|
⚲
|
| Keyboard |
| PFM Health Sciences LP
✚
|
|
|---|---|
| CRD # | 146747 |
| SEC # | 801-69012 |
| CIK # | 0001442756 |
| AUM | 1,266.8 M (2026-03-31) |
| Employees | 17 (41% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 415-281-1000 |
| Address | 50 California Street San Francisco, CA 94111 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001442756 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Tenet Healthcare Corp | 0.1 | ||
| United Therapeutics Corp | 0.1 | ||
| Lilly Eli & Co | 0.1 | ||
| Penumbra Inc | 0.0 | ||
| Axsome Therapeutics Inc | 0.0 | ||
| Ascendis Pharma A/S | 0.0 | ||
| Jazz Pharmaceuticals Inc | 0.0 | ||
| Neurocrine Biosciences Inc | 0.0 | ||
| Glaukos Corp | 0.0 | ||
| Inhibrx Biosciences Inc | 0.0 | ||
| Edwards Lifesciences Corp | 0.0 | ||
| Bridgebio Pharma Inc | 0.0 | ||
| Synta Pharmaceuticals Corp | 0.0 | ||
| Indivior PLC | 0.0 | ||
| UnitedHealth Group Inc | 0.0 | ||
| Magenta Therapeutics Inc | 0.0 | ||
| Abbott Laboratories | 0.0 | ||
| Revolution Medicines Inc | 0.0 | ||
| Acadia Healthcare Company Inc | 0.0 | ||
| Neogenomics Inc | 0.0 | ||
| Cooper Companies Inc | 0.0 | ||
| Natera Inc | 0.0 | ||
| Greatbatch Inc | 0.0 | ||
| Rhythm Pharmaceuticals Inc | 0.0 | ||
| Waters Corp /DE/ | 0.0 | ||
| Atlas Holdings Inc | 0.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | PFM Biotech Opportunities LP | 2023-03-01 | 68.2 M | |
| PE | PFM Meta LP | [2023-03-01] | 0.0 M | |
| Filed 2022-01-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | PFM Songbird LP | [2022-02-22] | 5.3 M | 1.9 M |
| Offered $5,312,896 · Filed 2021-10-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | PFM Healthcare Growth Equity Fund I LP | [2021-09-14] | 94.9 M | 39.7 M |
| Filed 2022-07-22 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | PFM Media Disruption Master Fund LP | [2019-02-21] | 15.1 M | 15.6 M |
| Filed 2018-10-12 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | PFM Global Long Alpha Institutional Master Fund LP | [2018-03-29] | 15.8 M | 15.5 M |
| Filed 2018-05-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | PFM Technology Perennial Master Fund LP | [2017-09-20] | 139.0 M | 161.0 M |
| Filed 2020-05-21 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | PFM Healthcare Long Master Fund LP | [2017-08-29] | 2.9 M | 4.5 M |
| Filed 2019-05-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | PFM Thematic Growth Institutional Master Fund LP | [2017-03-30] | 658.5 M | 400.9 M |
| Filed 2019-05-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | PFM Healthcare Emerging Growth Master Fund LP | [2015-07-07] | 284.8 M | 763.6 M |
| Filed 2019-05-02 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 1.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 1.3 |
| By Discretionary | ||
| Discretionary | 7 | 1.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 1.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.3 | |
| United States Persons | 1.0 | |
| Total | 7 | 1.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Christopher Bowring | Director | 177 | 35 | |
| Ian Goodall | Director | 141 | 33 | |
| Philip Cater | Director | 96 | 25 | |
| Christopher James | Executive Officer | 179 | 15 | |
| Mark Withy | Director | 28 | 4 | |
| William Goodell | Executive Officer | 23 | 3 | |
| Brian Grossman | Executive Officer | 34 | 2 | |
| Darin Sadow | Executive Officer | 28 | 2 | |
| Yuan Dubord | Executive Officer | 28 | 2 | |
| Eric Moore | Executive Officer | 23 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001442756] | |
| SC 13G | [0001442756] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $7.7B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | NO32JKYWYYFCHBKBPG50 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Pleiad Investment Advisors Limited
✚
|
1,351.8 M | |
|
FCO Advisors LP
✚
|
NY | 1,339.3 M |
|
Chilton Investment Company Inc
✚
|
CT | 1,323.2 M |
|
Framework Ventures Management LLC
✚
|
CA | 1,280.9 M |
|
Ospraie Management LLC
✚
|
NY | 1,259.7 M |
|
WEBS Creek Capital Management LP
✚
|
TX | 1,254.4 M |
|
Seven Grand Managers LLC
✚
|
NY | 1,235.3 M |
|
Wynkoop LLC
✚
|
CO | 1,217.3 M |
|
Hudson Cove Capital Management LLC
✚
|
NJ | 1,213.5 M |
|
Arlon Advisor LLC
✚
|
NY | 1,176.7 M |